*Review* **Roles Played by Biomarkers of Kidney Injury in Patients with Upper Urinary Tract Obstruction**

**Satoshi Washino 1,\*, Keiko Hosohata <sup>2</sup> and Tomoaki Miyagawa <sup>1</sup>**


Received: 28 June 2020; Accepted: 29 July 2020; Published: 31 July 2020

**Abstract:** Partial or complete obstruction of the urinary tract is a common and challenging urological condition caused by a variety of conditions, including ureteral calculi, ureteral pelvic junction obstruction, ureteral stricture, and malignant ureteral obstruction. The condition, which may develop in patients of any age, induces tubular and interstitial injury followed by inflammatory cell infiltration and interstitial fibrosis, eventually impairing renal function. The serum creatinine level is commonly used to evaluate global renal function but is not sensitive to early changes in the glomerular filtration rate and unilateral renal damage. Biomarkers of acute kidney injury are useful for the early detection and monitoring of kidney injury induced by upper urinary tract obstruction. These markers include levels of neutrophil gelatinase-associated lipocalin (NGAL), monocyte chemotactic protein-1, kidney injury molecule 1, N-acetyl-b-D-glucosaminidase, and vanin-1 in the urine and serum NGAL and cystatin C concentrations. This review summarizes the pathophysiology of kidney injury caused by upper urinary tract obstruction, the roles played by emerging biomarkers of obstructive nephropathy, the mechanisms involved, and the clinical utility and limitations of the biomarkers.

**Keywords:** upper urinary tract obstruction; kidney injury; biomarkers; neutrophil gelatinase-associated lipocalin; monocyte chemotactic protein-1; kidney injury molecule 1; cystatin C; vanin-1
